LBPH Company Profile and Key Details

Q: Who are the executives of LBPH?

Mr. Steven W. Spector J.D.Executive Vice President, Head of Bus. Devel. & Gen. CounselMr. Kevin R. LindPres, Chief Executive Officer, Sec. & DirectorGus CardenasVice President & Head of Quality AssuranceDr. Marco Peters Ph.D.Vice President & Head of Translational ScienceDr. Anne M. DanksVice President & Head of Preclinical Devel.Mr. Chadwick J. Orevillo MPHExecutive Vice President & Head of OperationsMs. Brandi L. Roberts CPA, M.B.A.ConsultantMegan E. KnightHead of Investor RelationsDr. Jodi ParsonsVice President & Head of Regulatory AffairsDr. Randall E. Kaye M.D.Executive Vice President & Chief Medical OfficerDr. Anne M. Danks Ph.D.Vice President & Head of Nonclinical Devel.Mr. Gus CardenasVice President & Head of Quality Assurance

NASDAQ : LBPH

Longboard Pharmaceuticals

$59.98

N/A-

At Close 4:00 PM

Not Actively Trading

59.16

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Longboard Pharmaceuticals, Inc. (LBPH) stock remained unchanged at -, trading at $59.98 on NASDAQ, unchanged from the previous close of -. The stock opened at -, fluctuating between $59.98 and $59.98 in the recent session.

Stock Snapshot

N/A

Prev. Close

2.34B

Market Cap

59.98

Day Low

-26.657777777777778

P/E Ratio

-2.25

EPS (TTM)

-2.13

Cash Flow per Share

N/A

Open

39.05M

Number of Shares

59.98

Day High

63.94%

Free Float in %

1.71

Book Value

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 13, 2024	59.98	59.98	59.98	59.98	0
Dec 12, 2024	59.98	59.98	59.98	59.98	0
Dec 11, 2024	59.98	59.98	59.98	59.98	0
Dec 10, 2024	59.98	59.98	59.98	59.98	0
Dec 09, 2024	59.98	59.98	59.98	59.98	0
Dec 06, 2024	59.98	59.98	59.98	59.98	0
Dec 05, 2024	59.98	59.98	59.98	59.98	0
Dec 04, 2024	59.98	59.98	59.98	59.98	0
Dec 03, 2024	59.98	59.98	59.98	59.98	0
Dec 02, 2024	59.98	59.98	59.98	59.98	0
Nov 29, 2024	59.99	60.03	59.98	59.98	654.87K
Nov 27, 2024	59.96	59.98	59.94	59.96	872.3K
Nov 26, 2024	59.92	59.95	59.88	59.95	1.08M
Nov 25, 2024	59.83	59.95	59.80	59.91	413K
Nov 22, 2024	59.80	59.83	59.77	59.80	1.29M
Nov 21, 2024	59.77	59.80	59.76	59.77	1.12M
Nov 20, 2024	59.77	59.83	59.75	59.77	743.56K
Nov 19, 2024	59.78	59.85	59.70	59.84	892.8K
Nov 18, 2024	59.68	59.81	59.68	59.75	454.91K
Nov 15, 2024	59.76	59.83	59.47	59.69	1.22M

Contact Details

La Jolla, CA 92037

United States

https://www.longboardpharma.com 619 592 9775

About Company

Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.

Stock Peers

ARGX

-29.4-3.20%

argenx SE$888.82 REGN

11.16+1.70%

Regeneron Pharmaceuticals, Inc.$667.17 MDGL

6.74+1.24%

Madrigal Pharmaceuticals, Inc.$551.25 UTHR

-0.53-0.10%

United Therapeutics Corporation$527.94 VRTX

1.64+0.34%

Vertex Pharmaceuticals Incorporated$479.00 KRYS

16.63+4.96%

Krystal Biotech, Inc.$351.82 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 ONC

BeOne Medicines AG$325.90 PRAX

-9.5-2.92%

Praxis Precision Medicines, Inc.$315.80 LGND

-3.03-1.01%

Ligand Pharmaceuticals Incorporated$297.50

Frequently Asked Questions

What is the current Longboard Pharmaceuticals, Inc. (LBPH) stock price?

Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) stock price is $59.98 in the last trading session. During the trading session, LBPH stock reached the peak price of $59.98 while $59.98 was the lowest point it dropped to. The percentage change in LBPH stock occurred in the recent session was N/A while the dollar amount for the price change in LBPH stock was -.

LBPH's industry and sector of operation?

The NASDAQ listed LBPH is part of Biotechnology industry that operates in the broader Healthcare sector. Longboard Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of LBPH?

Mr. Steven W. Spector J.D.
Executive Vice President, Head of Bus. Devel. & Gen. Counsel
Mr. Kevin R. Lind
Pres, Chief Executive Officer, Sec. & Director
Gus Cardenas
Vice President & Head of Quality Assurance
Dr. Marco Peters Ph.D.
Vice President & Head of Translational Science
Dr. Anne M. Danks
Vice President & Head of Preclinical Devel.
Mr. Chadwick J. Orevillo MPH
Executive Vice President & Head of Operations
Ms. Brandi L. Roberts CPA, M.B.A.
Consultant
Megan E. Knight
Head of Investor Relations
Dr. Jodi Parsons
Vice President & Head of Regulatory Affairs
Dr. Randall E. Kaye M.D.
Executive Vice President & Chief Medical Officer
Dr. Anne M. Danks Ph.D.
Vice President & Head of Nonclinical Devel.
Mr. Gus Cardenas
Vice President & Head of Quality Assurance

How LBPH did perform over past 52-week?

LBPH's closing price is 0% higher than its 52-week low of $59.98 where as its distance from 52-week high of $59.98 is 0%.

How many employees does LBPH have?

Number of LBPH employees currently stands at 50.

Link for LBPH official website?

Official Website of LBPH is: https://www.longboardpharma.com

How do I contact LBPH?

LBPH could be contacted at phone 619 592 9775 and can also be accessed through its website. LBPH operates from 4275 Executive Square, La Jolla, CA 92037, United States.

How many shares of LBPH are traded daily?

LBPH stock volume for the day was 0 shares. The average number of LBPH shares traded daily for last 3 months was 0.

What is the market cap of LBPH currently?

The market value of LBPH currently stands at $2.34B with its latest stock price at $59.98 and 39.05M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	50
Beta	1.09
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	50
Beta	1.09
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

LBPH Company Profile and Key Details

Longboard Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Earnings & Analyst Outlook

Company Overview

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Shareholding & Insider Activity

Valuation Metrics

Price Forecast & Outlook

Key Takeaways